Harvard Catalyst is supported by a five-year, $117.5 million Clinical and Translational Science Award (CTSA; awards UL1 RR 025758 and KL2 RR 025757) from the National Center for Research Resources, a part of the National Institutes of Health.
Harvard Catalyst receives an additional $75 million over five years, from: